multiple sclerosis

Biogen's Tecfidera Time-Out Pays Off
Motley Fool
Tue, 11/26/13 - 04:38 pm
Tecfidera
Biogen Idec
MS
multiple sclerosis
What Copaxone Profits? Yet Another Troubling Leak At Teva
Pharmalot
Mon, 11/25/13 - 06:23 pm
Teva
Copaxone
MS
multiple sclerosis
Biogen wins protection for MS drug Tecfidera in Europe
Yahoo/Reuters
Fri, 11/22/13 - 09:01 am
Biogen Idec
MS
multiple sclerosis
Europe
Tecfidera
What Does a Mixed FDA Verdict Mean for Sanofi's MS Drug?
Motley Fool
Mon, 11/18/13 - 08:24 am
FDA
Sanofi
MS
Lemtrada
multiple sclerosis
Teva Rejected by U.S. High Court Justice on Copaxone Patent
Bloomberg
Thu, 11/14/13 - 10:54 am
patents
Copaxone
Teva
Supreme Court
MS
multiple sclerosis
Sanofi MS Drug’s Mixed Verdict From FDA Panel Puzzles Analysts
Bloomberg
Thu, 11/14/13 - 08:56 am
Sanofi
multiple sclerosis
FDA
MS
Lemtrada
advisory panels
FDA panel supports approval of Sanofi MS drug Lemtrada, with reservations
Yahoo/Reuters
Wed, 11/13/13 - 05:36 pm
FDA
advisory panels
Sanofi
Lemtrada
MS
multiple sclerosis
FDA staffers throw cold water on Sanofi's Lemtrada hopes
Fierce Pharma
Fri, 11/8/13 - 11:10 am
FDA
Sanofi
Lemtrada
MS
multiple sclerosis
Tecfidera Succeeds in Protecting Biogen's MS Market Share From Novartis' Gilenya
Motley Fool
Sun, 11/3/13 - 12:12 pm
Gilenya
Novartis
MS
multiple sclerosis
Biogen Idec
Tecfidera
Teva Pharmaceuticals: Copaxone's Upcoming Expiration Continues To Depress Its Current Valuation
Seeking Alpha
Wed, 10/30/13 - 10:05 am
Teva
MS
multiple sclerosis
Copaxone
Biogen MS Drug Rollout Eyed Ahead Of Q3 Earnings
investors.com
Sat, 10/26/13 - 10:49 am
Biogen Idec
MS
multiple sclerosis
GW Pharma cannabis drug gets green light in France
Reuters
Mon, 10/21/13 - 08:39 am
GW Pharma
cannabis
France
Sativex
MS
multiple sclerosis
Teva Director: 'Generic Copaxone Will Come In 2015, If At All'
Pharmalot
Mon, 10/14/13 - 11:24 am
Teva
Copaxone
generics
MS
multiple sclerosis
Biogen Idec Dominant Player In Multiple Sclerosis Market
investors.com
Sat, 10/12/13 - 11:55 am
Biogen Idec
MS
multiple sclerosis
Genmab announces positive results for sclerosis drug candidate
Reuters
Thu, 10/10/13 - 06:19 pm
Genmab
MS
multiple sclerosis
ofatumumab
Merck Serono funds four MS projects
Pharma Times, UK
Wed, 10/9/13 - 09:04 am
Merck Serono
MS
multiple sclerosis
R&D
Experts thinks Biogen to likely be able to market Tecfidera in EU, says Leerink
Yahoo/Fly on the Wall
Mon, 10/7/13 - 11:01 am
Biogen Idec
multiple sclerosis
MS
Europe
Tecfidera
Is This Biotech Cornering the Market for MS Treatments?
Motley Fool
Sat, 10/5/13 - 09:52 am
Biogen Idec
MS
multiple sclerosis
Biogen's new MS drug maintains efficacy long term -study
Yahoo/Reuters
Fri, 10/4/13 - 10:18 am
MS
multiple sclerosis
Biogen Idec
Tecfidera
Teva says oral MS drug laquinimod may reduce brain tissue damage
Yahoo/Reuters
Tue, 10/1/13 - 10:59 am
Teva
MS
multiple sclerosis
laquinimod

Pages